✨ Free AI Report
Evolva Holding SA: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Evolva Holding SA
Company Research

Evolva Holding SA: Business Overview, Financials & Competitive Analysis

Evolva Holding SA scores 4/10 on the AskCyborg Cyborg Score (Weak). AVOID - Once-promising biotech company now operates as non-operating holding company pursuing acquisitions; original innovation assets no longer owned. Post-acquisition in 2024, Evolva Holding SA became a shell company with no operating business. The company is pursuing M&A opportunities but lacks meaningful revenue-generating operations or pipeline. The name change.

What is Evolva Holding SA's industry? Evolva Holding SA (evolva.com) operates in Biotech / Synthetic Biology (Historical); Non-Operating Holding Company (Current). AskCyborg classifies Evolva Holding SA under Biotech / Synthetic Biology (Historical); Non-Operating Holding Company (Current) in its company registry.

Evolva Holding SA is a Swiss biotech company that uses synthetic biology and precision fermentation technology to discover and develop innovative, sustainable ingredients for health, nutrition, wellness, flavors, frag...

4/ 10Weak

Cyborg Score thesis

AVOID - Once-promising biotech company now operates as non-operating holding company pursuing acquisitions; original innovation...

Read the full analyst-debate transcript →
Industry Biotech / Synthetic Biology (Historical); Non-Operating Holding Company (Current)
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Evolva Holding SA Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Evolva Holding SA

AskCyborg analysts argue the bull and bear cases for Evolva Holding SA across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Evolva Holding SA OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Evolva Holding SA Overview

Pro stress-test →

Evolva Holding SA is a Swiss biotech company that uses synthetic biology and precision fermentation technology to discover and develop innovative, sustainable ingredients for health, nutrition, wellness, flavors, fragrances, and cosmetics. The company was founded in 2004 and built its reputation around proprietary technology enabling the creation of high-value compounds derived from yeast.

Strategic Profile

Pro stress-test →

Evolva positioned itself as a synthetic biology innovator with a differentiated technological approach compared to traditional pharmaceutical chemistry. The company leveraged discovery partnerships with major players like Roche while developing its own pipeline of compounds including resveratrol, vanilla, pomecin, stevia, and saffron. In January 2024, the company's operating assets were acquired by Danstar Ferment AG (subsidiary of Lallemand Inc.), fundamentally transforming its strategic position.

Competitive Landscape

Pro stress-test →

Evolva historically competed in the synthetic biology and precision fermentation space with companies in biotech, flavors/fragrances, and natural ingredients sectors. Major partnerships included Roche for drug discovery. Post-acquisition, the competitive landscape is largely irrelevant as Evolva is no longer an operating biotech company.

Industry Context

Evolva Holding SA operates in Biotech / Synthetic Biology (Historical); Non-Operating Holding Company (Current).

Key facts

Founded: 2001 · Headquarters: Reinach, Switzerland

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Evolva Holding SA.

  • Fundamental transition: Operating business acquired by Lallemand/Danstar Ferment in Jan 2024; Evolva now shell company pursuing M&A
  • Technology legacy: Developed proprietary precision fermentation platform for creating natural ingredients using synthetic biology; assets now owned by acquirer
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2024Danstar Ferment AG (Lallemand subsidiary) completed acquisition of Evolva AG operating business
  • December 2023Evolva Holding shareholders approved acquisition by Danstar Ferment AG
  • +1 moreTrack every material event for Evolva Holding SA as it happens. Explore monitoring →
Get alerted when Evolva Holding SA has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Precision fermentation for natural ingredientsSynthetic biology platform for industrial biotech→Natural flavors and ingredients via biotechGene editing and synthetic biology applications→

Compare Evolva Holding SA with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Evolva Holding SA operates in Biotech / Synthetic Biology (Historical); Non-Operating Holding Company (Current). See how the rest of the sector scores on the Cyborg framework.

Browse Biotech / Synthetic Biology (Historical); Non-Operating Holding Company (Current) research →
NEW · MCP server

Ask your AI assistant about Evolva Holding SA

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Evolva Holding SA and its top competitor on Cyborg Score”
“What did Evolva Holding SA do this quarter?”
“Is Evolva Holding SA a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Evolva Holding SA do?+
Evolva Holding SA is a Swiss biotech company that uses synthetic biology and precision fermentation technology to discover and develop innovative, sustainable ingredients for health, nutrition, wellness, flavors, frag...
What is Evolva Holding SA's Cyborg Score?+
Evolva Holding SA has a Cyborg Score of 4/10 (Weak). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Evolva Holding SA's main competitors?+
Named competitors include Precision fermentation for natural ingredients, Natural flavors and ingredients via biotech. The full competitive landscape is in the AskCyborg report.
How can I get the full Evolva Holding SA research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Evolva Holding SA research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Evolva Holding SA over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biotech research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Aker BioMarine ASA7BICO Group6AFYREN